|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1991-5-23
|
|
pubmed:abstractText |
Adjuvant perioperative liver infusion chemotherapy with fluorouracil, mitomycin and heparin caused mild but significant myelosuppression in the first two postoperative weeks. This was associated with a slightly increased bleeding tendency. Mortality was not increased. Future trials might combine chemotherapy with hematopoietic growth factors in order to minimize myelosuppression.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0250-7005
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
365-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:1902076-Antineoplastic Agents,
pubmed-meshheading:1902076-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:1902076-Colonic Neoplasms,
pubmed-meshheading:1902076-Combined Modality Therapy,
pubmed-meshheading:1902076-Female,
pubmed-meshheading:1902076-Fluorouracil,
pubmed-meshheading:1902076-Follow-Up Studies,
pubmed-meshheading:1902076-Hemoglobins,
pubmed-meshheading:1902076-Heparin,
pubmed-meshheading:1902076-Humans,
pubmed-meshheading:1902076-Infusions, Intravenous,
pubmed-meshheading:1902076-Leukocyte Count,
pubmed-meshheading:1902076-Male,
pubmed-meshheading:1902076-Mitomycin,
pubmed-meshheading:1902076-Mitomycins,
pubmed-meshheading:1902076-Platelet Count,
pubmed-meshheading:1902076-Portal Vein,
pubmed-meshheading:1902076-Random Allocation,
pubmed-meshheading:1902076-Rectal Neoplasms
|
|
pubmed:articleTitle |
Hematological toxicity of adjuvant portal liver infusion with fluorouracil, mitomycin and heparin.
|
|
pubmed:affiliation |
Group for Epidemiologic and Clinical Cancer Research (SAKK), Berne, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study
|
